Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: a retrospective cohort study from the global collaborative network
Annals of Translational Medicine · 2026-06 · 14 (3) · 32-32
DOI: 10.21037/atm-2026-0131 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Annals of Translational Medicine, 2026-06. Verfasst von Omar Abdelhalim und 14 weiteren Autor:innen. Beteiligte Einrichtung: Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, NY, USA. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Icahn School of Medicine at Mount Sinai, Queens Hospital Center, New York, NY, USA.
- Hunt Regional Medical Center, Greenville, TX, USA.
- New York Medical College at St. Michael's Medical Center, Newark, NJ, USA.
- Cleveland Clinic Foundation, Cleveland, OH, USA.
- Department of Internal Medicine, Henry Ford Hospital, Detroit, MI, USA.
- Division of Endocrinology and Diabetes, Larner College of Medicine, University of Vermont, Burlington, VT, USA.
ORCID-Profile: Omar Abdelhalim, Mohammed Y Youssef, Sawsan Al-Lababidi, Mohamed H Eldesouki, Ahmed Mohamed, Mohammed Abusuliman, Mahmoud Nassar, Ahmed Salem, Ahmed Aref, Khaled M Elhusseiny, Chloe Lahoud, Zara Bhutta, Hazem Abosheaishaa
Zitieren
APA
Abdelhalim, O., Youssef, M. Y., Al-Lababidi, S., Eldesouki, M. H., Mohamed, A., Abusuliman, M., Nassar, M., Abushanab, M., Salem, A., Shaheen, H., Aref, A., Elhusseiny, K. M., Lahoud, C., Bhutta, Z., & Abosheaishaa, H. (2026). Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: a retrospective cohort study from the global collaborative network. Annals of Translational Medicine, 14(3), 32-32. https://doi.org/10.21037/atm-2026-0131
Vancouver
Abdelhalim O, Youssef MY, Al-Lababidi S, Eldesouki MH, Mohamed A, Abusuliman M, et al. Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: a retrospective cohort study from the global collaborative network. Annals of Translational Medicine. 2026;14(3):32-32. doi:10.21037/atm-2026-0131
BibTeX
@article{Abdelhalim2026,
author = {Abdelhalim, Omar and Youssef, Mohammed Y and Al-Lababidi, Sawsan and Eldesouki, Mohamed H and Mohamed, Ahmed and Abusuliman, Mohammed and Nassar, Mahmoud and Abushanab, Mohammad and Salem, Ahmed and Shaheen, Hassan and Aref, Ahmed and Elhusseiny, Khaled M and Lahoud, Chloe and Bhutta, Zara and Abosheaishaa, Hazem},
title = {Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: a retrospective cohort study from the global collaborative network},
journal = {Annals of Translational Medicine},
year = {2026},
volume = {14},
number = {3},
pages = {32--32},
doi = {10.21037/atm-2026-0131}
}
EUVIMED